Clinical Trial Detail

NCT ID NCT01591421
Title P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Patients With Metastatic or Advanced RAS-Wild Type Colorectal Cancer.
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors NCIC Clinical Trials Group
Indications

colorectal cancer

Therapies

BKM120 + Panitumumab

Age Groups: adult

Additional content available in CKB BOOST